BeStock  
Stocks › Biotechnology › DSGN

Design Therapeutics DSGN

US equityMarket cap rank #3510Biotechnology
$9.02 −$0.30 (-3.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $9.02 0.00%
Open$9.33
Prev close$9.32
Day range$8.96 – $9.57
Volume281.9K
Market cap$577.61M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership96.9%-0.38 pts vs. prior quarter
Institutions holding177+5 vs. prior quarter
Insider trades (recent)37 buys / 6 sellsNet buying
Short interest10.09% of floatDays to cover 16.2 · as of 30 Oct 2026
Short-sale volume share32.1%5-day average of daily volume

Short-sale volume as % of daily volume

14%26%38%50%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$829.2K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

+$610.6KSuper+$218.6KBig−$410.3KMid−$1.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 42.7% of shares outstanding.

Largest holders

  • Aseem Ansari11.98%
  • SR One Capital Management, LP10.19%
  • Sirenia Capital Management LP8.52%
  • Light Irrevocable Trusts5.99%
  • Star Irrevocable Trust5.99%
  • Quan Management LLC5.28%
  • Logos Global Management, L.P.4.68%
  • BlackRock4.24%

By investor type

  • Mutual Fund34.92%
  • Hedge Fund29.17%
  • VC/PE Fund17.70%
  • Individual/Insider13.76%
  • Private Company12.18%
  • Public Company2.24%
  • Government Pension Fund0.32%
  • Family Office/Trust0.16%

Reported short interest has risen from 9.47% to 10.09% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
State Street Global Advisors Mutual Fund 2026/Q3 +937,239 2.6%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +131,810 0.2%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +110,764 0.2%
Sirenia Capital Management LP Mutual Fund 2026/Q3 +5,453,736 8.5%
Frazier Life Sciences Management, LP VC/PE Fund 2026/Q3 +1,809,854 2.8%
Trails Edge Capital Partners, LP Hedge Fund 2026/Q3 +1,149,269 3.1%
Logos Global Management, L.P. Hedge Fund 2026/Q3 +1,050,000 4.7%
Caption Management, LLC Hedge Fund 2026/Q3 +1,031,390 1.7%
Driehaus Capital Management LLC Mutual Fund 2026/Q3 +916,128 4.2%
Sofinnova Investments, Inc. VC/PE Fund 2026/Q3 +865,135 1.4%
BlackRock Mutual Fund 2026/Q3 +526,260 4.3%
Artal Group S.A. VC/PE Fund 2026/Q3 +523,212 0.8%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +402,896 0.7%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +333,053 0.7%
Jacobs Levy Equity Management Inc Mutual Fund 2026/Q3 +276,212 0.9%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
8 Jun 2026 John Schmid Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Justin Gover Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 David Shapiro Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Rodney Lappe Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Simeon George Lead Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
8 Jun 2026 Heather Berger Independent Director Other Derivative Acquisition +30,000 $10.55 30,000
30 Mar 2026 David Shapiro Independent Director Other Derivative Acquisition +67,500 $10.64 7,500
1 Jan 2026 Pratik Shah Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson Other Derivative Acquisition +750,000 $9.10 750,000
1 Jan 2026 Justin Gover Independent Director Other Derivative Acquisition +45,000 $9.10 45,000
1 Jan 2026 Chris Storgard Chief Medical Officer Other Derivative Acquisition +250,000 $9.10 250,000
1 Jan 2026 Sean Jeffries Chief Operating Officer Other Derivative Acquisition +375,000 $9.10 375,000
1 Jan 2026 Julie Burgess Chief Accounting Officer Other Derivative Acquisition +150,000 $9.10 150,000
8 Dec 2025 Pratik Shah Co-Founder, President, CEO, Principal Financial Officer & Executive Chairperson Other Derivative Acquisition +1,050,000 $2.48 525,000
17 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -120,000 $7.43 –
13 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -620,000 $7.06 –
6 Nov 2025 Logos Global Management, L.P. Intent to Sell (Form 144) -415,000 $6.87 –
8 Sep 2025 Justin Gover Independent Director Other Derivative Acquisition +45,833 $6.64 15,833
12 Aug 2025 Logos Global Management, L.P. Open Market Disposition -562,627 $5.25 3,655,000
9 Jun 2025 John Schmid Independent Director Other Derivative Acquisition +19,000 $4.01 19,000
9 Jun 2025 Rodney Lappe Independent Director Other Derivative Acquisition +19,000 $4.01 19,000

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 6,311,677 10.1% 16.2
15 Oct 2026 6,653,634 10.6% 12.0
30 Sep 2026 6,616,513 10.6% 8.7
15 Sep 2026 5,461,508 8.7% 7.3
31 Aug 2026 5,542,463 8.9% 9.0
14 Aug 2026 5,925,557 9.5% 15.2

Discussion

No comments yet — be the first to weigh in on DSGN.

Sign in to join the discussion.

Scroll to Top